KMT2A and leukemia: The SPK111 peptide, which was derived from the PFWT peptide by conjugation with a modified HIV Tat protein domain, exhibited better in vivo stability and prolonged the survival of mice bearing MLL1-AF9 and MLL1-ENL rearranged leukemia cells [195].